|
gptkbp:instanceOf
|
gptkb:fentanyl_analogue
gptkb:opioid
|
|
gptkbp:antidote
|
gptkb:naloxone
|
|
gptkbp:CASNumber
|
79704-90-4
|
|
gptkbp:chemicalFormula
|
C23H30N2O
|
|
gptkbp:controlled_under
|
gptkb:United_Nations_Convention_on_Psychotropic_Substances
|
|
gptkbp:developedBy
|
gptkb:Russia
|
|
gptkbp:discoveredBy
|
1976
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
gptkbp:first_illicit_use
|
late 1970s
|
|
gptkbp:IUPACName
|
N-phenyl-N-[1-(1-phenylpropan-2-yl)piperidin-4-yl]propanamide
|
|
gptkbp:legalStatus
|
Schedule I controlled substance
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
350.5 g/mol
|
|
gptkbp:PubChem_CID
|
62713
|
|
gptkbp:relatedTo
|
fentanyl
3-methylfentanyl
|
|
gptkbp:riskFactor
|
high potential for abuse
fatal overdose
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
intravenous
|
|
gptkbp:sideEffect
|
addiction
overdose
respiratory depression
euphoria
analgesia
|
|
gptkbp:UNII
|
6Q1V1Y1Y1E
|
|
gptkbp:usedFor
|
gptkb:recreational_drug
|
|
gptkbp:bfsParent
|
gptkb:China_White
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
alpha-methylfentanyl
|